<table id="ID112" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="34%"></col>
<col width="33%"></col>
<col width="33%"></col>
<thead>
<tr>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Effect </content>
<content stylecode="bold">on </content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">of </content>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">or </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Clinical </content>
<content stylecode="bold">Comment </content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph></paragraph>
<paragraph stylecode="Footnote">↓= Decreased (induces lamotrigine gluronidation).
                                                    <br/>
</paragraph>
<paragraph stylecode="Footnote">↑= Increased (inhibits lamotrigine glucuronidation).
                                                    <br/>
</paragraph>
<paragraph stylecode="Footnote">?= Conflicting data.
                                                    <br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Estrogen-containing oral  contraceptive preparations  containing 30 mcg ethinylestradiol  and 150 mcg levonorgestrel
                                                <br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">↓ lamotrigine
                                                <br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">Decreased lamotrigine levels  approximately 50%.
                                                <br/>
<br/>
<br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">↓ levonorgestrel
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">Decrease in levonorgestrel component by 19%.
                                                <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Carbamazepine (CBZ) and  CBZ epoxide
                                                <br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">↓ lamotrigine
                                                <br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">Addition of carbamazepine decreases lamotrigine  concentration approximately 40%.
                                                <br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">? CBZ epoxide
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">May increase CBZ epoxide levels
                                                <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenobarbital/Primidone
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine  concentration approximately 40%.
                                                <br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenytoin (PHT)
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine  concentration approximately 40%
                                                <br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Rifampin
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine AUC  approximately 40%
                                                <br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Valproate
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">↑ lamotrigine
                                                <br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Toprule" valign="top">Increased lamotrigine concentrations slightly  more than 2-fold.
                                                <br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">? valproate
                                                <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">Decreased valproate concentrations an average of  25% over a 3-week period then stabilized in healthy volunteers;  no change in controlled clinical trials in epilepsy patients.
                                                <br/>
<br/>
<br/>
<br/>
</td>
</tr>
</tbody>
</table>